Uli Christian Broedl,Odd-Erik Johansen,Gabriel Woojai Kim,Eric Williams Mayoux,Afshin Salsali,Nima Soleymanlou,Maximilian von Eynatten,Hans-Juergen Woerle,David Z. I. Cherney,Bruce A. Perkins,Andreas
申请号：
US14918713
公开号：
US09949997B2
申请日:
2015.10.21
申请国别(地区):
US
年份:
2018
代理人:
摘要：
The present invention relates to certain SGLT-2 inhibitors for treating and/or preventing oxidative stress, for example in patients with type 1 or type 2 diabetes, as well as to the use of such SGLT-2 inhibitors in treatment and/or prevention of cardiovascular diseases in patients, for example type 1 or type 2 diabetes patients. The present invention further relates to certain SGLT-2 inhibitors for treating and/or preventing a metabolic disorder and preventing, reducing the risk of or delaying the occurrence of a cardiovascular event in patients, for example patients with type 1 or type 2 diabetes.
